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Summary
Background: An interlocked transcriptional-transla-
tional feedback loop (TTFL) is thought to generate the
mammalian circadian clockwork in both the central
pacemaker residing in the hypothalamic suprachias-
matic nuclei and in peripheral tissues. The core circa-
dian genes, including Period1 and Period2 (Per1 and
Per2), Cryptochrome1 and Cryptochrome2 (Cry1 and
Cry2), Bmal1, and Clock are indispensable components
of this biological clockwork. The cycling of the PER and
CRY clock proteins has been thought to be necessary to
keep the mammalian clock ticking.
Results: We provide a novel cell-permeant protein
approach for manipulating cryptochrome protein levels
to evaluate the current transcription and translation
feedback model of the circadian clockwork. Cell-perme-
ant cryptochrome proteins appear to be functional on
the basis of several criteria, including the abilities to (1)
rescue circadian properties in Cry12/2Cry22/2 mouse
fibroblasts, (2) act as transcriptional repressors, and
(3) phase shift the circadian oscillator in Rat-1 fibro-
blasts. By using cell-permeant cryptochrome proteins,
we demonstrate that cycling of CRY1, CRY2, and
BMAL1 is not necessary for circadian-clock function in
fibroblasts.
Conclusions: These results are not supportive of the
current version of the transcription and translation feed-
back-loop model of the mammalian clock mechanism, in
which cycling of the essential clock proteins CRY1 and
CRY2 is thought to be necessary.
Introduction
Circadian (daily) rhythms regulate gene-expression pat-
terns, cellular activities, and behavioral phenomena [1].
In mammals, a circadian oscillator in the suprachias-
matic nuclei (SCN) of the hypothalamus appears to be
a central pacemaker that coordinates circadian oscilla-
tors in peripheral tissues and cells, including liver,
lung, kidney, muscle, cornea, and fibroblasts [2–7]. A
network of evidence supports a model for the mamma-
lian clockwork that proposes autoregulatory transcrip-
tional and translational feedback loops (TTFLs) of key
‘‘clock proteins’’ that are rhythmically abundant and
that interact with one another to feed back upon the
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Northwestern University, Evanston, Illinois 60208.transcriptional activity of their respective genes [8–11].
In mammals, positive transcriptional ‘‘drive’’ is provided
by a heterodimer of the bHLH-PAS factors, BMAL1 and
CLOCK (and/or NPAS2 [12]), and this heterodimer acti-
vates transcription at E box enhancers [13]. Negative
feedback in the system is primarily accomplished by
Period (especially PER1 and PER2) and Cryptochrome
(CRY1 and CRY2) gene products that translocate to
the nucleus and repress the transcription of their own
genes [14–23]. Although an important role for posttrans-
lational modification of key mammalian clock proteins is
recognized [24–26], the rhythmic expression of mRNAs
and proteins encoded by key clock genes has led to
the understandable conclusion that these rhythmic
expression patterns are essential [8, 9, 14–16, 19, 20,
27–29]. However, this is obviously not necessarily true;
an essential gene product might have a rhythmic
expression pattern that is not inevitably functional. For
example, in plants, LhcII transcript levels and transla-
tional rates exhibit daily or circadian oscillations, but
these rhythmic patterns are not converted into down-
stream patterns of LHCII protein abundance [30, 31].
The TTFL model can be used to predict whether spe-
cific components need to oscillate [8–11, 32, 33]. Cycling
of the positive components (especially CLOCK and
BMAL1) appears to be unnecessary for circadian pre-
cession [34–36], and consequently, testing the TTFL’s
prediction of rhythmically expressed factors has fo-
cused upon the negative limb components PER1/2
and CRY1/2. Consistent with the TTFL model, constitu-
tive overexpression of mCry1 mRNA in mammalian cells
has been reported to enhance damping [37]. In addition
to constitutive-overexpression studies, however, an
important support for the TTFL model in other organ-
isms has been perturbation analyses where experimen-
tal expression of clock proteins as pulses or steps was
used to determine whether the oscillator is reset in
a phase-dependent fashion. For example, in the cases
of Drosophila, Neurospora, and cyanobacteria, induc-
ible promoters that rapidly turn on or off were used to
drive expression of clock genes, thereby eliciting phase
setting or phase shifting [38–41]. This approach has not
yet been reported in mammals for pulse or step pertur-
bations, presumably because of the lack of an inducible
promoter system in which clock-protein expression can
be turned on or off rapidly [42, 43].
A better methodology for perturbation analyses is
needed to provide definitive tests of the predictions of
the TTFL model in mammalian cells. An alternative
approach that has not yet been applied to the study of
circadian rhythms is to fuse a protein transduction do-
main (PTD) to a clock protein and transduce it directly
across the cell membrane. This novel method would
allow the rapid introduction of a clock protein into cells
without the complications of transcriptional or posttran-
scriptional regulation. If the turnover rate of the modified
clock protein is sufficiently high, this technology would
permit the administration of pulses of the clock protein
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1092Figure 1. Uptake of Cell-Permeant Crypto-
chrome Proteins into Rat-1 Fibroblasts
(A) Schematic structure of the recombinant
CP proteins.
(B) Affinity-purified CP-CRY1 and CP-CRY2
proteins expressed in E. coli.
(C) Rat-1 cells were incubated with 50 nM of
fluorescein-labeled CP-CRY1 (C1), CP-CRY2
(C2), CP-mutCRY1 (C3), CP-CRE (C4), or
FITC (no protein) (C5). After a 30 min incuba-
tion, cells were treated with proteinase K to
remove any fluorescein-labeled protein that
nonspecifically adhered to the surface of the
cells.as well. In other applications, PTDs have been used to
import functional peptides and proteins into multiple
cell types so as to probe signal transduction pathways,
to introduce recombinases, to alter cell-division kinet-
ics, and to act for other purposes [44–49]. The wide
range of cell types and the ease of translocation across
the plasma membrane overcome the limitations of other,
more invasive, methods of introducing proteins directly
into cells such as microinjection or membrane-permea-
bilizing reagents [44, 49, 50]. By using this technology
to test predictions of the circadian TTFL model in mam-
malian fibroblasts, we found that cell-permeant CRY
proteins (CP-CRYs) (1) can rescue the arhythmia of
Cry12/2Cry22/2 mammalian fibroblasts, (2) can phase
shift the fibroblast oscillator, (3) can upregulate BMAL1
expression levels, and (4) can demonstrate that cycling
of CRY1, CRY2, and BMAL1 proteins is not necessary
for clock function in mammalian fibroblasts. Therefore,
in contrast to the current TTFL model of the mammalian
clockwork, our results question whether rhythmicity in
the abundances of mCRY1 and mCRY2 is essential for
operation of the mammalian circadian oscillator.
Results
Translocation of Cell-Permeable Mouse CRY1
and CRY2 into Mammalian Cells
Cell-permeant-protein technology has used PTDs that
are composed of either (1) positively charged residues
such as the TAT peptide [44] or a series of arginine res-
idues [45] or (2) hydrophobic residues [46–48]. We chose
the latter type of PTD for making cell-permeant mouse
CRY1 and CRY2 (CP-CRY1 and CP-CRY2), as shown
in Figure 1A. Recombinant CP-CRY1 and CP-CRY2 fu-
sion proteins have a C-terminal hydrophobic sequence,
AAVLLPVLLAAP from Kaposi FGF-4 (called the MTS for
‘‘membrane-transduction sequence’’), which can medi-
ate uptake of proteins directly through membranes
[46], and a N-terminal NLS (nuclear localization signal)
from simian virus 40 large T antigen to ensure the trans-
location of the protein into the nucleus (and the NLS
has additionally been found in some cases to aid the
translocation across the plasma membrane as well
[47]). A His6 tag was included for protein purification.The CP-CRYs can be expressed as soluble proteins in
E. coli and purified (Figure 1B). For testing the uptake
of CP-proteins in cultured cells, fluorescein-labeled
CP-proteins were incubated with Rat-1 fibroblasts and
HEK293 cells. CP-CRYs, CP-mutCRY1, and CP-CRE
are taken up into Rat-1 fibroblasts (Figure 1C) and into
HEK293 cells (data not shown). There appears to be
some aggregation of CP-CRY1, CP-mutCRY1, and CP-
CRE in the cells that might have cytoplasmic loci; these
might be analogous to the cytoplasmic loci found for
PER and TIM in Drosophila [51], whereas CP-CRY2
appears to be more homogeneously distributed. In all
cases, however, there appears to be nonaggregated
CP proteins throughout the cytoplasm and nuclei. As
has been found for CP proteins in other studies, the
transduction efficiency of CP-CRYs into fibroblasts is
approximately 95%. Uptake of extracellular CP-CRYs
can also be detected by immunoblotting of treated cells
with CRY1 and CRY2 polyclonal IgG antibodies. When
CP-CRY1 or CP-CRY2 is present continuously in the
medium, the intracellular levels of CP-CRY1 or CP-
CRY2 are present at high levels that do not fluctuate
with a circadian period (Figure S1 in the Supplemental
Data available online).
Repression of BMAL1/CLOCK-Mediated
Transcription by CP-CRYs
A standard assay for CRY activity is the inhibition of
BMAL1/CLOCK-dependent transactivation of E box-
containing promoters [19, 52]. In transient-transfection
assays, cotransfected hamster Bmal1 (haBmal1) and
mouse Clock (mClock) can activate the E box-contain-
ing PK2 promoter (PPK2; see [53]), and this activation
can be significantly repressed by cotransfected CP-
mCry1 that is intracellularly expressed under the control
of PCMV (Figures 2A and 2B). It also can be suppressed
by the extracellular addition of CP-CRYs (Figures 2A
and 2B). Repression by either intracellularly expressed
CP-CRY1 or by extracellularly applied CP-CRY1 was
dose dependent (Figure 2B and Figure S2). We used
a cell-permeant version of Cre Recombinase (CP-CRE)
that has previously been shown to translocate into cells
and confer intracellular loxP-specific recombination ac-
tivity [47] as a control protein for our studies. CP-CRE
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1093Figure 2. Repression of BMAL1/CLOCK-Mediated Transcription by CP-CRY1 and CP-CRY2
HEK293 cells were transfected with haBmal1, mouse Clock, and an E box-containing promoter PPK2-driven luciferase reporter (PPK2::luc).
(A) Intracellularly expressed CRY (PCMV::Cry1) and extracellularly applied CP-CRYs on PPK2 activity were evaluated with a luciferase assay of PK2
promoter activity. The concentrations of CP-CRY1, CP-CRY2, and CP-CRE proteins were 250 nM.
(B) Both transfected PCMV::Cry1 and extracellularly applied CP-CRY can inhibit PPK2 activity. Extracellularly applied CP-CRY1 and CP-mutCRY1
both inhibit PPK2 activity in a dose-dependent fashion, but CP-mutCRY1 is less effective than CP-CRY1. Protein concentrations are as follows: +,
5 nM; ++, 50 nM; and +++, 250 nM. The plotted values are mean6SD of three replicates. Asterisks indicate significant differences from haBmal1/
mClock controls at the p < 0.01 level (Student’s t test).uses the same MTS and NLS as our CP proteins, and it
translocates into fibroblasts (Figure 1C4), but it does
not repress PPK2::Fluc activity when it is added to the
extracellular medium (Figure 2A). As another control,
a mutant CP-CRY1 (CP-mutCRY1) was constructed,
on the basis of a study showing that mutation of aspar-
tate residue 387 of mouse CRY1 to alanine (D387A)
results in a reduced (but not eliminated) inhibition of E
box-containing promoters [54]. In transient-transfection
assays, both intracellularly expressed and extracellu-
larly applied CP-mutCRY1 showed significantly less
inhibition than CP-CRY1 at low dosages. As found in
the original publication [54], however, the D387A mutant
is able to inhibit E box promoters at high dosage
(Figure 2B and Figure S2). The data in Figure 2 show
the suppressive action on PPK2::Fluc activity, but essen-
tially identical results were obtained for the repression of
PmPer1::Fluc activity by CP-CRY (data not shown).
CP-CRY1 and CP-CRY2 Can Rescue Circadian
Properties in mCry12/2mCry22/2 Mouse Fibroblasts
In fibroblasts and SCN slices derived from mice in which
the mCry1 and mCry2 genes have been knocked out
(mCry12/2mCry22/2), mPer1 and mPer2 RNA levels are
arrhythmic and expressed at middle to high values com-
pared with wild-type mouse fibroblasts and SCN slices
[5, 18]. In fibroblasts derived from mCry12/2mCry22/2
double-knockout mice [55], we found that PER1 levels
did not oscillate and were higher than those in fibro-
blasts derived from wild-type mice (Figures 3A and 3B).
After treatment with CP-CRY1 + CP-CRY2, the PER1
level in knockout fibroblasts was reduced from the high
levels that are diagnostic of mCry12/2mCry22/2 fibro-
blasts to levels similar to that of the wild-type fibroblasts
(Figures 3A and 3B). This effect is probably mediated by
the suppressive activity of cryptochromes on the
BMAL1/CLOCK complex [19].
CP-CRY1 and CP-CRY2 can also rescue the rhythmic-
ity of mCry12/2mCry22/2 fibroblasts. We transfectedwild-type and mCry12/2mCry22/2 fibroblasts with a
PBmal1::Fluc luminescence reporter plasmid by nucleo-
fection. Wild-type mouse fibroblasts express a circadian
rhythm of luminescence, whereas mCry12/2mCry22/2
fibroblasts are arrhythmic (Figure 3C). However,
mCry12/2mCry22/2 fibroblasts treated with CP-CRY1 +
CP-CRY2 recovered rhythmicity. The data depicted in
Figure 3C are detrended data because the lumines-
cence rhythms of these mouse fibroblasts—even of the
wild-type fibroblasts—are consistently less robust than
that of the Rat-1 fibroblasts shown below. These data
indicate that CP-CRY1 and CP-CRY2 are functionally
active in vivo.
CP-CRY1 and CP-CRY2 Induce BMAL1
but Not CLOCK Expression
Coordination between the positive (BMAL1 and CLOCK/
NPAS2) and negative (PER1/2 and CRY1/2) limbs of the
mammalian TTFL is facilitated by the orphan nuclear
receptor REV-ERBa—the BMAL1/CLOCK heterodimer
activates REV-ERBa, which then represses further
Bmal1 transcription [34, 56]. CRY proteins repress the
activity of BMAL1/CLOCK, thereby repressing REV-
ERBa expression [34]. Therefore, because CRY proteins
repress the repressor of BMAL1 (i.e., REV-ERBa), CRY
proteins activate Bmal1 transcription [57]. Moreover,
CRY1 binds to the C terminus of BMAL1 and protects
BMAL1 from degradation [36]. Therefore, CP-CRY pro-
teins could enhance BMAL1 levels both by transcrip-
tional activation of Pbmal1 activity and by inhibition of
BMAL1 degradation. On the basis of these predictions,
we confirmed the functional activity of CP-CRY1 and
CP-CRY2. With conditions in which control endogenous
levels of BMAL1 are undetectable by immunoblotting
(‘‘PBS’’ in Figure 4A), CP-CRE does not elevate
BMAL1, but both CP-CRY1 and CP-CRY2 dramatically
upregulate BMAL1 protein levels within 30 min after
treatment with the CP proteins (Figures 4A and 4B).
This upregulation is at least 10- to 20-fold and is
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1094Figure 3. Circadian Properties Can Be
Rescued by CP-CRYs in Cry12/2Cry22/2
Knockout Mice Fibroblasts
(A) mPER1 expression level is high and
arrhythmic in Cry12/2Cry22/2 mouse fibro-
blasts. Treatment with CP-CRY1 and CP-
CRY2 reduces mPER1 expression levels to
wild-type levels.
(B) Quantification of results shown in (A).
Protein levels of mPER1 were normalized to
the actin loading control.
(C) ‘‘Rescue’’ of circadian rhythmicity in
Cry12/2Cry22/2 knockout mice fibroblasts.
The PBmal1::Fluc luminescence reporter was
introduced to the fibroblasts by nucleo-
fection. After CP-CRY1 and CP-CRY2 treat-
ment, the PBmal1::Fluc expression level is
elevated and rhythmicity is recovered. In the
wild-type mouse fibroblasts, rhythms are
sustained in both the untreated and the CP-
CRY1- + CP-CRY2-treated cell lines. Data
were detrended with LumiCycle software.
Colors represent the following: wild-type
(blue), wild-type + CP-CRYs (green), knock-
out (red), and knockout + CP-CRYs (black).constitutive (Figure S3). This effect is likely to be medi-
ated (at least partially) by induction of PBmal1 because
PBmal1 activity is stimulated acutely by treatment with
CP-CRY proteins in both Rat-1 and mCry12/2mCry22/2
fibroblasts (Figure S4). Pulse treatments of CP-CRY1 or
CP-CRY2 for 3 hr or 6 hr upregulate BMAL1 for only
the time of exposure to these proteins. After wash out
of CP-CRY1, the upregulated BMAL1 disappears within
1 hr (Figure 4B). As was true for the transient-transfec-
tion assay of PPK2 activity (Figure 2), CP-mutCRY1
(D387A) is less active than CP-CRY1 in the induction of
BMAL1; i.e., a low concentration (5 nM) of CP-mutCRY1
is less effective, whereas higher concentrations of CP-
mutCRY1 (25 and 100 nM) appear to be equivalent to
those of CP-CRY1 (Figure 4C). Finally, CP-CRYs do
not nonspecifically induce all proteins in Rat-1 fibro-
blasts (or even all core clock proteins) because neither
CP-CRY1 nor CP-CRY2 had a significant effect on
CLOCK protein levels (Figure S5). The data of Figure 4A
show clearly that the intracellular activity of CP-CRY is
not rhythmic, as judged by the activation of BMAL1
levels. Apparently, extracellular CP-CRY is continuously
entering the cells, where it is inactivated or degraded
relatively rapidly as judged by the rapid decline in
BMAL1 levels when extracellular CP-CRY is removed
(Figure 4B).
Phase Shift of the Rhythm in Rat-1 Fibroblasts
by CP-CRYs
As judged by the upregulation of BMAL1 levels (Figure 4)
and PBmal1 activity (Figure S4), the CP-CRY proteins are
functionally active soon after they are administered in
the extracellular medium. This makes them ideal for per-
turbation experiments. We used Rat-1 fibroblasts that
have been stably transfected with a PPer2::Fluc reporter
because they exhibit robust circadian oscillations of
luminescence for several days after synchronization by
10 mM forskolin. The addition of either CP-CRY1 orCP-CRY2 (‘‘step’’ treatments, i.e., continuous treat-
ments) can phase shift the PPer2::Fluc reporter rhythm
in a phase-dependent manner, whereas CP-CRE and
PBS have no effect. Step treatments of CP-CRY1 or
CP-CRY2 can elicit phase shifts up to 3 hr (either
advances or delays, depending upon the phase of the
treatment onset; Figure 5). At low concentrations
(5 nM), CP-mutCRY1 has less (or no) phase-resetting
activity effect on the Rat-1 rhythms (Figure 5B), and
this finding is consistent with its reduced efficacy in
the transient-transfection assay (Figure 2B). When the
data for CP-CRY1 and CP-CRY2 are plotted as phase-
response curves (PRCs), the resetting effects are clearly
phase dependent (Figure 5D) and stable (Figure 5C). The
phase position of PRCs for CP-CRY1 versus CP-CRY2 is
similar, consistent with the similar phasing of CRY1 and
CRY2 expression [28], but the PRC for CP-CRY2 may be
slightly delayed relative to that of CP-CRY1 (Figure 5D).
The phase resetting and BMAL1 activation we observe
with CP-CRY1 and CP-CRY2 is likely to be due to
a CRY-specific action and not due to a nonspecific
increase of membrane permeability. This was demon-
strated by the observation that none of the CP proteins
stimulated a Ca2+ influx into fibroblasts under conditions
in which ATP does elicit a Ca2+ flux (Figure S6).
There were two surprises in the data shown in Figure 5.
First, the continuous treatments with CP-CRY1 or CP-
CRY2 caused phase resetting but did not cause a period
change (Figure 5C). Second, there was no acute repres-
sive effect on PPer2 activity at the time of CP-CRY addi-
tion as would have been predicted by the data derived
from the transient-transfection assay (Figure 2 and
[19]). In fact, at most phases when CP-CRY1 or CP-
CRY2 was added, the acute effect on PPer2 activity
was either stimulatory (as shown in Figure 5A) or had
no effect. (Also note the acute stimulation of PBmal1 in
Figure S4.) This discrepancy will be addressed in the
Discussion.
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for the Circadian Oscillations of Rat-1 Fibroblasts
Ueda and coworkers [37] have reported that intracellular
overexpression of mCry1 from the PCMV promoter in-
hibits rhythmicity in transiently transfected Rat-1 fibro-
blasts. CP-CRY1 and CP-CRY2 afford an alternative
approach to address the issue of CRY suppression of
rhythmicity. As shown in Figure 4A, the addition of either
CP-CRY1 or CP-CRY2 results in a 103 to 203 BMAL1
overexpression that persists as long as the CP protein
is present in the extracellular medium. Although the
BMAL1 level is not clamped at an absolutely constant
level, it is clamped at a very high level and its fluctuations
are not circadian. Nevertheless, Figure 6 shows that
treatment with either CP-CRY1 or CP-CRY2 or both
does not suppress the circadian clock, as monitored
by rhythmicity of the PPer2::Fluc reporter in Rat-1 cells.
Table 1 summarizes the data from four separate exper-
iments that show the addition of CP-CRY1 or CP-CRY2,
or both, does not significantly enhance the damping rate
of the rhythm.
Discussion
Manipulating Intracellular Clock-Protein
Concentrations with Cell-Permeant Proteins
Direct manipulation of clock-protein abundances in
Neurospora, Drosophila, and cyanobacteria has been
accomplished by use of inducible promoters to drive
expression of clock genes to elicit phase setting or
Figure 4. Impact of CP-CRY1 and CP-CRY2 Treatment upon
BMAL1-Protein Abundance in Rat-1 Fibroblasts as Measured by
Immunoblotting
(A) BMAL1-protein expression in response to continuous treatment
of CP-CRY1, CP-CRY2, or CP-CRE. PBS is the phosphate-buffered
saline control.
(B) BMAL1 expression in response to 3 hr or 6 hr pulse treatments of
CP-CRY1.
(C) Comparison of the BMAL1 expression level of Rat-1 cells treated
with different concentrations of CP-mCRY1 or CP-mutCRY1 as
compared with the actin control.phase shifting [38–41]. On the other hand, rapid transi-
tions of the abundance of clock proteins have not
been reported for mammalian studies involving either in-
ducible promoter systems or transfected DNA plasmids
[37, 58–60]. For example, a study that applied a doxy-
cycline-responsive promoter system to drive mPER2
expression in mammalian fibroblasts used the system
only for constitutive on or off expression rather than as
pulses or steps [58]. Moreover, even when mPer2
mRNA transcription is constitutively driven in mamma-
lian cells, posttranscriptional processes confer rhyth-
micity on the protein’s abundance [59, 60], as had
already been reported for Drosophila PER [61]. Another
approach has been to transiently transfect mammalian
cells with a construct driving clock-gene expression
from a constitutive promoter; an investigation using
that strategy reported that constant expression of
mCry1 abolished circadian rhythmicity [37]. We have
taken a different approach toward manipulating the in-
tracellular levels of clock proteins. Our cell-permeant-
protein strategy enabled the perturbation of CRY levels
without the complications of transcriptional or transla-
tional regulation. Moreover, the intracellular activity of
CP-clock proteins can be rapidly turned on or off; in
the case of our studies, we have used the induction of
BMAL1 protein as a gauge of the intracellular activity
of the extracellularly applied CP-CRYs (Figure 4A).
BMAL1 levels changed rapidly in response to the addi-
tion or removal of extracellular CP-CRYs (Figure 4B).
This rapid response demonstrates the usefulness of
using CP-proteins for perturbation analyses of circadian
clocks.
We found that step treatments reset phase and that
a PRC composed of both advance and delay shifts
can be obtained from these stimuli. These step treat-
ments of CP-CRYs do not cause a significant change
in period, nor do they suppress the amplitude of the
rhythm (see next section). Surprisingly, even though
CP-CRYs enhance PBmal1 activity as expected (Fig-
ure S4; see [34, 57]), CP-CRYs do not acutely repress
PmPer2 activity in cells in which the reporter’s lumines-
cence is continuously monitored, whereas in transiently
transfected HEK293 cells, CP-CRYs repressed BMAL1/
CLOCK activation of the E box-containing promoters
PPK2 (Figure 2) and PmPer1 (not shown). These differ-
ences in the acute repression of PPer activity may stem
from the fact that BMAL1 and CLOCK are usually over-
expressed from plasmids in the standard transient-
transfection assay (as shown in Figure 2 and Figure S2),
and therefore the stoichiometries of transcriptional
factors are different from the case of our stably trans-
fected Rat-1 reporter cells that have only chromosomal
copies of Bmal1 and Clock.
Does the Clock Require Cyclic Expression
of Clock Proteins?
The current model of the mammalian clockwork is based
on a TTFL model that posits central clock proteins being
transcribed and translated rhythmically in an ‘‘autoregu-
latory’’ negative-feedback loop. A crucial prediction of
the model is that there will be at least one essential clock
protein whose oscillation is necessary. The TTFL model
has been mathematically modeled with realistic values
for state variables and parameters assigned to the
Current Biology
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Rhythms in Rat-1 cells with stably transfected PPer2::Fluc reporters were initiated by a 2 hr forskolin pulse (10 mM).
(A) CP-CRY1 (50 nM) was added to the assay medium at the phases indicated by arrows. Addition of CP-CRE (50 nM) or PBS were controls.
(B) CP-CRY1 is more effective than CP-mutCRY1 as a phase-shifting agent at a 5 nM concentration.
(C) Regression analyses of CP-CRY1-induced phase shifts. The left panel shows phase advance, and the right panel shows phase delay; open
symbols are CP-CRE-treated controls, and filled symbols are CP-CRY1-treated samples.
(D) PRCs to step treatments of CP-CRY1 and CP-CRY2 on Rat-1 fibroblasts. Black and blue symbols are CP-CRY1 and CP-CRY2 treatments,
respectively. Red symbols are CP-CRE treatments. Error bars represent 6 SD.known components of this clockwork [32, 33]. At the
current time, essential components of the mammalian
clockwork include PER1/2, CRY1/2, BMAL1, and
CLOCK/NPAS2. For which of these clock proteins can
it be shown that rhythmic abundance is indispensable?
Rhythmicity of the positive elements CLOCK and
BMAL1 does not appear to be necessary [34–36].
CLOCK is not rhythmically expressed in Rat-1 fibro-
blasts (Figure 4D), although it might exhibit low-ampli-
tude oscillations in some mammalian tissues as inferred
from the low-amplitude mRNA-abundance rhythms
seen in some peripheral tissues [62]. BMAL1 is rhythmi-
cally expressed, but several studies have shown that
constitutive expression of BMAL1 does not interfere
with normal clock operation in animals [34, 35] or in
cell cultures [36]. We also find by using our cell-perme-
ant-clock-protein approach that the constitutive overex-
pression of BMAL1 evoked by treatment with CP-CRY1
or CP-CRY2, or both, does not significantly affect the
circadian oscillator in Rat-1 cells (Figures 4A and 6).
On the other hand, rhythmicity of the levels of the
essential negative elements PER1/2 and CRY1/2 has
been thought to be indispensable. Ueda and coworkers
[37] report that the overexpression of mCry1 from
a transfected plasmid abolishes rhythmicity. By usingcell-permeant CRY proteins, we obtained a different re-
sult. CP-CRY1 or CP-CRY2 treatment, or both, causes
a large and constitutive increase of BMAL1 levels in
Rat-1 fibroblasts (Figure 4), indicating continued intra-
cellular activity of the cell-permeant CRY proteins. How-
ever, this treatment does not abolish (or even signifi-
cantly dampen) the oscillator as judged by the rhythm
of PPer2 activity (Figure 6 and Table 1). Our results are
not consistent with the conclusions of Ueda and co-
workers. However, our methods are different from their
methods; by using cell-permeant clock proteins, we
directly perturb the cellular levels of CRY proteins,
whereas the intracellular overexpression methodology
of Ueda and coworkers implicates additional layers of
transcriptional and posttranscriptional regulation [37].
Moreover, by assaying the activation of BMAL1 by CP-
CRYs, we could ascertain the relative dose of active
cryptochrome, whereas in the study of Ueda and co-
workers, there was no way of knowing how much the
CRY levels have been elevated.
Another important methodological distinction that
might explain the discrepancy between our results and
those of Ueda and coworkers [37] is that different PPer2
elements were used in the luminescence reporters:
Our PPer2 region was larger (21670 to +53; see [7]),
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Does Not Suppress Circadian Rhythmicity of
the PPer2::Fluc Reporter in Rat-1 Cells
CP-proteins were added at the time indicated
by the arrow (concentration = 50 nM for each
protein).whereas their PPer2 region was considerably smaller
(2219 to +76; see [37]). Therefore, because our PPer2::
Fluc reporter includes more potential regulatory sites,
it is probable that our results reflect a broader spectrum
of regulatory inputs to PPer2 activity. Finally, it might be
argued that the cell-permeant recombinant proteins
used in this study lack CRY’s usual cofactors [21, 22]
and therefore behave differently from endogenously
produced CRY that might contain a full complement of
cofactors. However, recombinant CP-CRY represses
PPK2 activity in the transcriptional assay (Figure 2), indi-
cating that it is functionally active; moreover, spectral
measurements of CP-CRY confirm that it has incorpo-
rated the cofactors FAD and pterin (Figure S7).
Broader Implications
Do our results topple the TTFL model? Certainly not.
Rhythmic abundance(s) of the essential clock proteins
PER1/2 may still be required for a functional clockwork.
A number of studies support the necessity of PER1 or
PER2 rhythms, or both, in animals [63, 64] or in cell cul-
tures [58–60]. Our results indicate that rhythmicity of the
essential clock proteins CRY1/2 is not necessary and fo-
cus attention upon PER1/2 as the bastion upon which
rhythmic transcription and translation could be founded.
Nevertheless, it might be prudent to consider whether it
is time for a major tune-up of the TTFL model for the
mammalian clockwork. Such a re-evaluation has oc-
curred in the case of the circadian-clock mechanism in
cyanobacteria, where the same kind of evidence that
supports a TTFL in the mammalian clockwork was pre-
viously used to support a TTFL mechanism in cyanobac-
teria [39, 41, 65]. Recent studies have shown that a TTFL
mechanism is not necessary in cyanobacteria under
some conditions (e.g., DD; see [65]). Moreover, three cy-
anobacterial clock proteins purified and mixed in a test
tube can reconstitute a circadian oscillation in vitro
[66, 67]. This result unequivocally demonstrates that
a posttranslational circadian oscillator can operate un-
der some conditions without a negative-feedback tran-
scriptional and translational loop, and this insight could
be relevant to the case of mammalian clocks.
Is it possible that—by analogy with the cyanobacterial
system—there is a core mammalian clockwork that
is purely posttranslational? This possibility cannot be
ignored, and it is possible that our results with CP-
CRY proteins intimate that underlying posttranslational
clock. An intriguing final speculation upon the discrep-
ancy between our results and those of Ueda andcoworkers [37] is that the intracellular expression of
CRY1 in their study has the effect of continuously flood-
ing the cells with newly synthesized protein that is not
posttranslationally modified, whereas our CP-CRYs
have already incorporated the FAD/pterin cofactors
(Figure S7) and may be otherwise posttranslationally
modified. Perhaps if a posttranslational oscillator is the
core mammalian clockwork, the introduction of post-
translationally modified CRY (as with CP-CRYs) may
perturb the core oscillator less than the new synthesis
of unmodified CRY proteins. It may be in the fullness
of time that this era of re-evaluation will lead to minor al-
terations of our understanding of the mammalian clock-
work and that the TTFL model will emerge triumphant.
On the other hand, this time of re-evaluation may lead
to a very different comprehension of the mammalian
clock mechanism.
Experimental Procedures
Expression and Purification of Cell-Permeant CRY1
and CRY2 Proteins
NLS-mCry1-MTS and NLS-mCry2-MTS were constructed by ampli-
fication of mouse Cry1 (NM_007771) and mouse Cry2 (NM_009963)
sequences with primers A and B for mCry1 and primers C and
D for mCry2 (see below) (templates were a gift from Dr. Steven
Reppert). The PCR products were cloned into the expression vector
pET28a+ (Novagen). The resulting constructs were used to express
NLS-mCRY1-MTS (=CP-mCRY1) and NLS-mCRY2-MTS (=CP-
mCRY2) fusion proteins that were purified by metal affinity chroma-
tography as described in the Supplemental Data. As a control, a mu-
tant NLS-CRY1-MTS (CP-mutCRY1 with D387A) was constructed on
the basis of the sequence described in [54]. For the transient-trans-
fection assay of PPK2 activity, the following constructs were made in
pcDNA3.1: pPCMV::NLS-mCry1-MTS, pPCMV::NLS-mCry2-MTS, and
pPCMV::NLS-mutCry1-MTS.
Primer A: 50-GACACATATGCCCAAGAAGAAGAGAAAGATGGG
GGTGAACGCC GTGCAC-30
Primer B: 50-CGTCTCTCGAGTTACGGTGCGGCAAGAAHAACA
GGGAGAAGAAC GGCTGCGTTACTGCTCTGCCGCTGG-30
Primer C: 50-GACACATATGCCCAAGAAGAAGAGAAAGATGGC
GGCGGCTGCTG TGGTG-30
Primer D: 50-GTCTCTCGAGTTACGGTGCGGCAAGAAGAACAG
GGAGAAGAAC GGCTGCGGAGTCCTTGCTTGCTGGCT-30
Uptake of CP Proteins
The intracellular presence of CP-CRY proteins in Rat-1 fibroblasts
and HEK293 cells was demonstrated by fluorescence microscopy.
Purified CP proteins were labeled with fluorescein isothiocyanate
(FITC) with a FITC-labeling kit according to the manufacturer’s in-
structions (Promega). After extensive dialysis against PBS for re-
moval of free FITC, 25 nM concentrations of labeled CP-CRY1,
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Damping Rate (d)
Treatment Exp. 1 Exp. 2 Exp. 3 Exp. 4
CP-CRY1 2.09 6 0.26 1.70 6 0.08 2.06 6 0.01 1.54 6 0.04
CP-CRY2 1.89 6 0.21 1.64 6 0.12 2.08 6 0.08 1.59 6 0.03
CP-CRY1 + CP-CRY2 1.96 6 0.12 — — 1.65 6 0.03
CP-CRE 2.01 6 0.14 1.73 6 0.08 2.04 6 0.04 1.63 6 0.19
PBS — 1.73 6 0.09 2.03 6 0.06 1.67 6 0.12
Damping rates were determined by LUMICYCLE data-analysis software (Actimetrics). The damping rate (d) is the number of days (as 24 hr
increments) required for the amplitude of the rhythm to decrease to 1/e (w36.8 %) of the starting value [6]. Values in the table are mean damping
rate 6SD for each treatment (n = 4 for experiments 1–3, n = 3 for experiment 4). A two-factor ANOVA analysis revealed that there are not signif-
icant differences among the five treatments in any of the four experiments (p value of 0.27), but among the four experiments there are differences
in the average damping rate that might be attributable to differences in the condition of the fibroblasts in the various experiments.CP-CRY2, CP-mutCRY1, and CP-CRE were added to cultured
HEK293 cells and Rat-1 fibroblasts for 30 min (‘‘CP-CRE’’ = CP-
Cre recombinase; see [47, 48]). Then, cells were washed with PBS
and treated with proteinase K (5 mg/ml) for 10 min at 37C. Proteinase
K is a broad spectrum protease that was used for eliminating non-
specific adherence of proteins to the cell surface, thereby distin-
guishing between CP proteins translocated into cells from those
sticking to the outside of the cell. Cells were then washed three
times with PBS and observed with a fluorescence microscope
(Axioscope; Zeiss) with a CCD camera (Princeton Instruments).
Transient-Transfection Assay
HEK293 cells were grown at 37C in DMEM (11965-092, GIBCO/Invi-
trogen) supplemented with 10% FBS, 50 units/ml penicillin, and
50 mg/ml streptomycin. Approximately 2 3 104 cells were seeded
in each well in a 96-well plate 1 day before transfection. When the
cells reached 90%–95% confluency, they were transfected with Lip-
ofectamine 2000 (Invitrogen) with various combinations of the fol-
lowing constructs (all in pcDNA3.1): 100 ng pPCMV::mClock, 100 ng
pPCMV::haBmal1, 0.5 ng pPCMV::Rluc, and/or 100 ng pPPK2::Fluc.
Twenty-four hours after transfection, 250 nM CP-CRY1, 250 nM
CP-CRY2, 250 nM CP-mutCRY1, and 250 nM CP-CRE were added
to the medium and incubated for 4 hr. Then, the cells were lysed
with passive lysis buffer and firefly luciferase (Fluc), and Renilla
(Rluc) luciferase activities were assayed with the Dual-Luciferase
Assay Kit (Promega).
‘‘Rescue’’ of Circadian Properties in mCry12/2mCry22/2
Mouse Fibroblasts
Wild-type and Cry12/2Cry22/2 double knockout mouse fibroblasts
(provided by Dr. Aziz Sancar) were cultured at 37C in DMEM
(11965-092, GIBCO/Invitrogen) supplemented with 10% FBS,
50 units/ml penicillin, and 50 mg/ml streptomycin. For testing the ef-
fect of CP-CRY treatment on PER1 levels, 1 3 106 mouse fibroblast
cells were seeded in 35 mm dishes 2 days before treatment with CP
proteins. Then, both wild-type and knockout fibroblasts were
treated with forskolin (10 mM) for 2 hr to synchronize the cells in
the population (this incubation included CP proteins for the samples
to be treated). After this synchronization treatment, the cells were
washed with DMEM and resuspended in DMEM without or with
0.1 mM CP-CRY1 + 0.1 mM CP-CRY2. Every 4 hr thereafter, cells
were washed with cold PBS twice and lysed. Proteins in the lysates
were separated by SDS-PAGE (in 7.5% acrylamide gels) and then
transferred to nitrocellulose membranes for immunoblotting. Anti-
mPER1 polyclonal IgG (#516045, Calbiochem) was used for detec-
tion of the PER1 levels.
For ‘‘rescue’’ of rhythmicity in Cry12/2Cry22/2 double-knockout
mouse fibroblasts, 1 3 106 cells were seeded in 35 mm dishes
2 days before transfection. After reaching 90% confluency, cells
were transfected by ‘‘nucleofection’’ electroporation with 2 mg of
the PBmal1::Fluc reporter plasmid in accordance with the manufac-
turer’s protocol (NHDF Nucleofector Kit # VPD-1001, Amaxa Biosys-
tems). After electroporation, cells were grown at 37C in DMEM +
10% FBS for 1 day. Then, wild-type fibroblasts were treated with
forskolin (10 mM) for 2 hr. Knockout fibroblasts were treated with
forskolin (10 mM) + 0.1 mM CP-CRY1 + 0.1 mM CP-CRY2 for 2 hr. After
this treatment, the medium was replaced with DMEM + 10% FBSincluding luciferin (0.1 mM) and, in the case of the ‘‘rescue’’ samples,
also including 0.1 mM CP-CRY1 and 0.1 mM CP-CRY2. The dishes
were sealed and luminescence was monitored in an automated lumi-
nescence recording apparatus designed for circadian experiments
(the ‘‘LumiCycle,’’ Actimetrics) at 36C.
Immunoblotting
Rat-1 cells stably transfected with the PPer2::Fluc reporter construct
[7] were cultured and synchronized with forskolin as above. Eigh-
teen hours after forskolin synchronization, 50 nM CP-CRY1, 50 nM
CP-CRY2, 50 nM CP-CRE, 50 nM CP-mutCRY1, and PBS were
added to cells. Every 4 hr after the treatment onset, cells were
washed twice with ice-cold PBS and lysed in 100 ml lysis buffer (lysis
buffer: 50 mM Tris-HCl [pH 7.5], 150 mM NaCl, and 1% NP40). Lysate
proteins were separated by SDS-PAGE (in 10% gels) and then trans-
ferred to nitrocellulose membranes for immunoblotting. Primary
antibodies were rat anti-mCRY1 monoclonal IgG (from Dr. Aziz
Sancar), rabbit anti-mCRY2 IgG (Alpha Diagnostic International),
rabbit anti-BMAL1 polyclonal IgG (Oncogene catalog #PC539, lot#
D13920-1; see Figure S8 for its characterization), and rabbit anti-
CLOCK polyclonal IgG (#233170, Calbiochem). The secondary anti-
bodies were AP-conjugated anti-rabbit IgG (#S3731, Promega) and
AP-conjugated anti-rat IgG (Promega, #S3831).
Phase Shift of Fibroblast Oscillations Elicited
by CP-CRY Proteins
These experiments used the Rat-1 line that has been stably trans-
fected with a PPer2::Fluc reporter construct and that shows a robust
circadian rhythm of luciferase activity [7]. The cells were cultured in
DMEM (11965-092, GIBCO/Invitrogen) supplemented with 5% FBS,
50 units/ml penicillin, and 50 mg/ml streptomycin in a 5% CO2 incu-
bator at 37C. Approximately 5 3 105 cells were seeded in a 35 mm
dish at least 5 days before the experiment. Three days after the cells
reached 100% confluency, the cells were treated with 10 mM forsko-
lin (Sigma) for 2 hr to synchronize the oscillators among the cells in
the population. At the end of the forskolin treatment, the medium
was replaced with assay medium (DMEM without phenol red, sup-
plemented with bicarbonate [350 mg/L], 5% FBS, 10 mM HEPES
[pH 7.2], antibiotics [25 units/ml penicillin and 25 mg/ml streptomy-
cin], and 0.1 mM luciferin [Promega]). Culture dishes were sealed
with a 40 mm microscope glass cover and high-vacuum grease to
prevent the evaporation of culture medium. The luminescence
rhythm was monitored in the LumiCycle (Actimetrics). For the
‘‘step’’ treatments, CP-CRY1 or CP-CRY2, as well as 50 nM of the
control proteins CP-CRE and CP-mutCRY1, were added to the cell
samples at different phases and left continuously with the cells
thereafter while the luminescence patterns were recorded for
5 days or more. Regression analyses to determine period and phase
of the luminescence rhythms were performed with the Chrono II
program (courtesy of Dr. Till Roenneberg). Rate of damping was
assessed with the software included with the Lumicycle (Actimetrics).
Supplemental Data
Additional Experimental Procedures and eight figures are available
at http://www.current-biology.com/cgi/content/full/17/13/1091/
DC1/.
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